Charles Schwab Investment Management Inc Savara Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Savara Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 963,821 shares of SVRA stock, worth $2.73 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
963,821
Previous 911,617
5.73%
Holding current value
$2.73 Million
Previous $3.87 Million
23.47%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SVRA
# of Institutions
133Shares Held
149MCall Options Held
67.6KPut Options Held
29.4K-
Nea Management Company, LLC Timonium, MD24.5MShares$69.3 Million7.93% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$41.2 Million12.07% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$35 Million6.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.31MShares$23.5 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$23.1 Million1.86% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $323M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.